Stay updated on Uproleselan Combo in R/R AML Chinese Patients Clinical Trial
Sign up to get notified when there's something new on the Uproleselan Combo in R/R AML Chinese Patients Clinical Trial page.

Latest updates to the Uproleselan Combo in R/R AML Chinese Patients Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe study record history now includes a new revision entry v3.3.4 and removes the previous revision v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check29 days agoChange DetectedRevision: v3.3.3 was added; HHS Vulnerability Disclosure and Revision: v3.3.2 were removed.SummaryDifference0.2%

- Check51 days agoChange DetectedThe page history shows a new revision entry v3.3.2 and removal of v3.3.1, which are minor updates to the historical record.SummaryDifference0.1%

- Check58 days agoChange DetectedA new revision entry v3.3.1 was added to the history, and revision v3.2.0 was removed. This is metadata about the page's revision history rather than substantive study details.SummaryDifference0.1%

- Check66 days agoChange DetectedThe warning notice about government funding was removed from the top of the page. This change removes a site-wide operating-status notice that previously appeared.SummaryDifference0.8%

- Check80 days agoChange DetectedThe Record History shows two recruitment-status updates (2021-11-22 and 2025-06-24), with the 2025 version including a termination notice and related study detail revisions.SummaryDifference0.1%

Stay in the know with updates to Uproleselan Combo in R/R AML Chinese Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Uproleselan Combo in R/R AML Chinese Patients Clinical Trial page.